Patients with myeloma and higher concentrations of BAFF show worse PFS (32), mostly as BAFF promote the survival of both B cell (immature, naive and activated B cells) and MM cell by active the NF-B pathway (84). The gene discussed is TNFSF13B; the disease is plasma cell myeloma.